thinXXS Microtechnology
Private Company
Total funding raised: $5.8M
Overview
thinXXS Microtechnology is a specialized contract development and manufacturing organization (CDMO) focused on plastic microfluidic components and systems. Its core value proposition is de-risking and accelerating the product development cycle for diagnostic and life science companies, enabling them to bring complex microfluidic assays to market faster. Backed by the global infrastructure of its parent company, IDEX Health & Science, thinXXS combines deep engineering expertise with scalable manufacturing capabilities, supplying millions of high-precision parts annually to industry leaders.
Technology Platform
Vertically integrated platform for design, micro-injection molding, assembly, and packaging of plastic microfluidic consumables. Includes proprietary technologies like air-free filled blister packs and scalable automation for mass production.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes against other specialized microfluidic CDMOs (e.g., Micronit, Dolomite, microfluidic ChipShop) and large diagnostic companies' in-house manufacturing capabilities. Differentiation is achieved through deep vertical integration, over 20 years of expertise, a focus on high-volume manufacturability, and the global backing of IDEX Health & Science.